ARTICLE | Clinical News
Aptosyn exisulind apoptosis augmenting compound regulatory update
November 1, 1999 8:00 AM UTC
The FDA accepted for filing CLPA's NDA for Aptosyn to treat familial adenomatous polyposis (FAP), which predisposes people to colon cancer. ...